Biosafety, risk assessment and regulation of plant-made pharmaceuticals

Methods in Molecular Biology

Volumn 483, Issue , 2009, Pages 341-353

  Sparrow, Penelope A C ^a   Twyman, Richard M ^b  

^a JOHN INNES CENTRE   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Biosafety; Containment; Field release; Genetically modified (GM); Host plant; Plant made pharmaceuticals (PMPs); Regulation; Risk assessment

Indexed keywords

DRUG;

ARTICLE; HUMAN; METABOLISM; RISK ASSESSMENT; TRANSGENIC PLANT;

HUMANS; PHARMACEUTICAL PREPARATIONS; PLANTS, GENETICALLY MODIFIED; RISK ASSESSMENT;

EID: 60549102476     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-407-0_20     Document Type: Review

References (13)

1. Dawson, W. (2005) Herbal medicines and the EU Directive. J. Royal Coll. Phys. Edinburgh 35, 25-27.
2. ISAAA (2006) Global Status of Commercialized Biotech/GM Crops: 2006. http://www.isaaa.org/.
3. Spok, A. (2007) Molecular farming on the rise - GMO regulators still walking a tight-rope . Trends Biotechnol. 25, 74-82.
4. CPMP (2002) Points to Consider on Quality Aspects of Medicinal Products Containing Active Substances Produced by Stable Transgene Expression in Higher Plants (CPMP/BWP/764/02). European Agency for the Evaluation of Medicinal Products (EMEA).
5. FDA (2002) Guidance for Industry. Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for use in Humans and Animals. Food and Drug Administration.
6. CPMP (2006) Draft Guideline on the Quality of Biological Active Substances Produced by Stable Transgene Expression in Higher Plants. European Agency for the Evaluation of Medicinal Products (EMEA).
7. Twyman, R.M., Stoger, E., Schillberg, S., Christou, P., and Fischer, R. (2003) Molecular farming in plants: Host systems and expression technology. Trends Biotechnol. 21, 570-578.
8. Twyman, R.M., Schillberg, S., and Fischer, R. (2005) Transgenic plants in the biopharmaceutical market. Expert. Opin. Emerg. Drugs 10, 185-218.
9. Union of Concerned Scientists (2006) UCS Position Paper: Pharmaceutical and Industrial Crops. UCS. http://www.ucsusa.org/food-and- environment/genetic-engineering/ucs-position-paper.html
10. Commandeur, U., Twyman, R.M., and Fischer, R. (2003). The biosafety of molecular farming in plants. AgBiotechNet 5, 1-9.
11. Dunwell, J. (2005) Technologies for Biological Containment of GM and Non-GM Crops. DEFRA Contract CPEC 47.
12. Sparrow, P.A.C., Irwin, J., Dale, P., Twyman, R.M., and Ma, J.K.C. (2007) Pharma-Planta: Road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res. 16, 147-161.
13. Spök, A., Twyman, R.M., Fischer, R., Ma, J. K.C., and Sparrow, P.A.C. (2008) Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends in Biotech. 26(9): 506-517.